Kairos Pharma, Ltd. (KAPA)
NYSEAMERICAN: KAPA · Real-Time Price · USD
1.070
-0.050 (-4.46%)
At close: Aug 13, 2025, 4:00 PM
1.100
+0.030 (2.80%)
Pre-market: Aug 14, 2025, 9:06 AM EDT
Kairos Pharma Market Cap
Kairos Pharma has a market cap or net worth of $18.03 million as of August 14, 2025.
Market Cap
18.03M
Enterprise Value
14.99M
1-Year Change
n/a
Ranking
Category
Stock Price
$1.07
Market Cap Chart
Since the IPO on September 16, 2024, Kairos Pharma's market cap has decreased from $33.39M to $18.03M, a decrease of -46.00%. That is a compound annual growth rate of -49.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 18.03M | -7.67% |
| Dec 31, 2024 | 19.53M | -41.52% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |